Actively Recruiting

Age: 18Years +
All Genders
NCT06018961

Study of Postoperative Ileus in Digestive Surgery

Led by University Hospital, Toulouse · Updated on 2025-12-31

161

Participants Needed

2

Research Sites

111 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Toulouse

Lead Sponsor

I

Institut National de la Santé Et de la Recherche Médicale, France

Collaborating Sponsor

AI-Summary

What this Trial Is About

Post-operative ileus is a temporary stoppage of bowel function following surgery. Indeed it can occur in 20% of cases during post-operative follow-up of bowel surgery. The absence of resumption of transit can lead to the implementation of specific treatments such as the placement of a nasogastric tube and drug treatments. To date, the definition of this event is not accepted by everyone and is not based on reproducible evaluation criteria. The main objective of this study is to evaluate a score used to date to define postoperative ileus, the IFEED score, and to compare it to the length of postoperative stay.

CONDITIONS

Official Title

Study of Postoperative Ileus in Digestive Surgery

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient entering our care sector for surgical management of a pathology affecting the digestive tract
  • Colorectal cancer
  • Chronic inflammatory bowel disease
  • Colonic diverticulosis
Not Eligible

You will not qualify if you...

  • Patient treated for digestive resection with associated resection procedure or to be treated with intraperitoneal chemotherapy
  • Patient presenting during hospitalization with an ileus secondary to another intra-abdominal complication
  • Patient cared for in an emergency
  • Hepatic resection or other associated metastatic site
  • Multiple digestive resection
  • Colorectal anastomosis less than 7 cm from the anal margin (below the Pouch of Douglas)
  • Patient with American Society of Anesthesiologists physical status (ASA) score > 2
  • Patient with an Eastern Cooperative Oncology Group (ECOG) Performance Status Scale >2
  • Pregnant or breastfeeding women
  • Patient under a protection regime for adults (guardianship, curators, safeguard of justice)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

CHU de Toulouse

Toulouse, France, 31000

Actively Recruiting

2

INSERM

Toulouse, France

Not Yet Recruiting

Loading map...

Research Team

G

Guillaume LE COSQUER, MD

CONTACT

E

Etienne BUSCAIL, MD-PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here